Hans Wandall

Scientific Co-Founder at GO Therapeutics - Cambridge, MA, US

Hans Wandall's Contact Details
HQ
617-816-4637
Location
Company
GO Therapeutics
Hans Wandall's Company Details
GO Therapeutics logo, GO Therapeutics contact details

GO Therapeutics

Cambridge, MA, US • 10 - 19 Employees
BioTech/Drugs

GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.

Drug development Antigen development Antobody developement O-glycosylation Glycoproteomics Glycopeptides Cellular engineering
Details about GO Therapeutics
Frequently Asked Questions about Hans Wandall
Hans Wandall currently works for GO Therapeutics.
Hans Wandall's role at GO Therapeutics is Scientific Co-Founder.
Hans Wandall's email address is ***@gotherapeutics.com. To view Hans Wandall's full email address, please signup to ConnectPlex.
Hans Wandall works in the Biotechnology industry.
Hans Wandall's colleagues at GO Therapeutics are Aaron Groen, Vikas Sharma, Kostadin Petrov, Steph Barr, Edwin Tan, Nisha shrestha, Aaron PhD and others.
Hans Wandall's phone number is 617-816-4637
See more information about Hans Wandall